AACR Welcomes New Members to the Board of Directors and Nominating Committee
PHILADELPHIA — The members of the American Association for Cancer Research will welcome Carlos L. Arteaga, M.D., as president-elect 2013-2014 on Tuesday, April 9, at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10.
Arteaga is professor of medicine and cancer biology at Vanderbilt University School of Medicine where he holds the Donna S. Hall chair in breast cancer research. He serves as associate director for clinical research and director of the Breast Cancer Research Program of the Vanderbilt-Ingram Cancer Center in Nashville, Tenn. He will begin serving his one-year term as AACR president in April 2014.
“Dr. Arteaga is an internationally recognized leader in translational and clinical research,” said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. “His extraordinary expertise in these areas will be a tremendous asset to the AACR as we continue to seek innovative new ways to accelerate the translation of pioneering research discoveries into improvements in patient care. We are delighted to welcome him on board as the new president-elect.”
In his vision statement, Arteaga vowed to leverage the resources of the AACR to increase and sustain funding of multidisciplinary, multi-investigator, basic science-based translational and clinical research in cancer. Further, he will make it a priority to promote and retain young laboratory-based investigators and physician-scientists in cancer research.
In addition, the members have elected five distinguished scientists to serve on the AACR Board of Directors for the 2013-2016 term: Mary C. Beckerle, Ph.D.; Michael A. Caligiuri, M.D.; Hans Clevers, M.D., Ph.D.,; Elizabeth M. Jaffee, M.D.; and Victor E. Velculescu, M.D., Ph.D.
Mary C. Beckerle, Ph.D., is chief executive officer and director of the Huntsman Cancer Institute at the University of Utah in Salt Lake City. She is also associate vice president for cancer affairs, distinguished professor of biology and adjunct professor of oncological sciences at the University of Utah.
Beckerle is currently a member of the AACR Science Policy and Government Affairs Committee and served as a scientific lecturer at the Meet-the-Expert Session, “Genesis and Impact of Cytoskeletal Changes in Transformed Cells,” at the AACR Annual Meeting 2011.
Michael A. Caligiuri, M.D., is chief executive officer of the James Cancer Hospital and Solove Research Institute at The Ohio State University in Columbus, Ohio. He is also director of The Ohio State University Comprehensive Cancer Center; vice president for health sciences, cancer programs; chair in cancer research at the John L. Marakas Nationwide Insurance Enterprise Foundation; and professor in the departments of molecular virology, immunology, medical genetics and internal medicine at Ohio State University.
Caligiuri is currently chairperson of the AACR Publications Committee and a member of the Council of Scientific Advisors, the Science Policy and Government Affairs Committee, the Clinical and Translational Cancer Research Committee and the steering committee for the Cancer Immunology Working Group. He was also chairperson for the Annual Meeting Program Committee in 2009 and a member of the editorial boards of Molecular Cancer Therapeutics and Clinical Cancer Research.
Hans Clevers, M.D., Ph.D., is president of The Royal Netherlands Academy of Arts and Sciences in Amsterdam and professor in molecular genetics at the Academic Biomedical Center at the University of Utrecht, in Utrecht, Netherlands.
Clevers has served on several AACR selection committees including the AACR-Princess Takamatsu Memorial Lectureship Selection Committee, the Landon Basic Prize Selection Committee and the Laboratory Research Awards Selection Committee. He was also on the editorial board of Molecular Cancer Research.
Elizabeth M. Jaffee, M.D., is a professor of oncology and pathology at Johns Hopkins University School of Medicine in Baltimore, Md., active staff in oncology at Johns Hopkins Hospital, associate director for translational research and co-director of the Gastrointestinal Cancers Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. She is also medical director of the Johns Hopkins Oncology Center Cell Processing and Gene Therapy Facility, deputy director of the Institute for Translational and Clinical Research and on the faculty of the graduate programs in immunology, cellular and molecular medicine, and pharmacology at the Johns Hopkins University School of Medicine.
Jaffee is currently chairperson of the AACR Cancer Immunology Working Group and a member of the Tumor Microenvironment Working Group and the Science Policy and Government Affairs Committee. She has served as co-chairperson of Mentored Grants and Research Fellowships and of the special conferences, “Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances” and “Tumor Immunology: Basic and Clinical Advances.” She was also an associate editor of Cancer Research and member of the editorial boards of Clinical Cancer Research and Molecular Cancer Therapeutics.
Victor E. Velculescu, M.D., Ph.D., is professor of oncology at Johns Hopkins University School of Medicine, co-director of the Cancer Biology Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and director of cancer genetics at the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University.
Velculescu is chairperson of the AACR Basic Cancer Research Grants Scientific Review Committee and a member of the Education and Training Committee. Additionally, he was a member of the Annual Meeting 2012 Program Committee, the Breast Cancer Research Foundation-AACR Grants for Translational Breast Cancer Scientific Review Committee and was a keynote speaker at the 2007 International Conference on Molecular Diagnostics in Cancer Therapeutic Development.
On Tuesday, April 9, at 7 a.m. ET, during the AACR Annual Meeting Business Meeting, the AACR leadership will induct Charles L. Sawyers, M.D., as president of the AACR.
Sawyers is chair of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center in New York, N.Y., and a Howard Hughes Medical Institute investigator. He is also a professor in the Cell and Developmental Biology Program at the Joan and Sanford I. Weill Graduate School of Medical Sciences of Cornell University. He is co-leader of the Stand Up To Cancer-Prostate Cancer Foundation Prostate Cancer Dream Team: Precision Therapy of Advanced Prostate Cancer, and is scientific editor of Cancer Discovery.
Sawyers will succeed Frank McCormick, Ph.D., F.R.S., D.Sc. (hon.), director of the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. McCormick holds the E. Dixon Heise distinguished professorship in oncology and the David A. Wood distinguished professorship of tumor biology and cancer research at UCSF. Additionally, he is the associate dean of the UCSF School of Medicine and a distinguished professor in residence in the department of microbiology and immunology as well as in the department of biochemistry and biophysics.
McCormick served with distinction as AACR president for the 2012-2013 term and will assume the role of past-president (2013-2014).
In addition, the following renowned scientists have been elected to serve as members of the Nominating Committee for the 2013-2015 term: Elizabeth H. Blackburn, Ph.D.; Kenneth W. Kinzler, Ph.D.; Scott W. Lowe, Ph.D.; and Martine J. Piccart, M.D., Ph.D.
Elizabeth Blackburn, Ph.D., is the Morris Herzstein Professor of Biology and Physiology in the departments of biochemistry and biophysics, and microbiology and immunology at the University of California, San Francisco.
Blackburn, recipient of the 2009 Nobel Prize in Physiology or Medicine, is currently scientific editor of Cancer Discovery, deputy editor of Cancer Prevention Research and a member of the Stand Up To Cancer Scientific Advisory Committee, the AACR Cancer Prevention Committee and the Science Policy and Government Affairs Committee. Blackburn has also served as AACR president from 2010 to 2011, chairperson of the Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research Selection Committee, co-chairperson of the AACR Cancer Progress Report 2011 Writing Committee, keynote speaker at the 2010 AACR International Conference on Frontiers in Cancer Prevention Research and chairperson of the AACR Award for Lifetime Achievement in Cancer Research Committee. She was also on the board of directors (2006-2009) and a senior editor of Molecular Cancer Research.
In addition, Blackburn will be inaugurated into the first class of the Fellows of the AACR Academy during the Annual Meeting.
Kenneth W. Kinzler, Ph.D., is director of the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and professor of oncology at Johns Hopkins University School of Medicine.
He is currently a member of the Fight Colorectal Cancer-AACR Award Selection Committee and the Publications Committee. Kinzler has served as chairperson of the Editor-in-Chief Search Committee for Molecular Cancer Research and the AACR Laboratory Research Awards Selection Committee. He was also a member of the board of directors (2008-2011).
Scott W. Lowe, Ph.D., is an investigator at the Howard Hughes Medical Institute, member of Memorial Sloan-Kettering Cancer Center and chair of the Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center in New York, NY. He is also adjunct associate professor in the Department of Physiology and Biophysics at Stony Brook University School of Medicine in Stony Brook, N.Y. and an adjunct professor at Cold Spring Harbor Laboratory, in Cold Spring Harbor, N.Y.
Lowe is chairperson of the AACR International Conference on Frontiers in Basic Cancer Research 2013. He was a co-committee member and keynote speaker at the 2011 AACR-Japanese Cancer Association joint conference, “The Latest Advances in Liver Cancer Research: From Basic Science to Therapeutics,” chairperson of AACR Laboratory Research Awards Selection Committee, chairperson of the special conference, “Mouse Models of Cancer” and a member of the board of directors (2005-2008).
Martine J. Piccart, M.D., Ph.D., is a professor of oncology at the Université Libre de Bruxelles in Brussels, Belgium, and head of the medicine department at the Institut Jules Bordet in Brussels. She is president-elect and a board member of the European CanCer Organization and president of the European Society for Medical Oncology.
Piccart is a member of the AACR-Women in Cancer Research Council. She was co-chairperson of the 2010 Annual Meeting Education Committee, the 2010 AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, and the 2004 and 2010 Annual Meeting Program Committees.
In addition, Piccart will be inaugurated into the first class of the Fellows of the AACR Academy during the Annual Meeting.
Press registration for the AACR Annual Meeting 2013 is free to qualified journalists and public information officers.
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org.
In Washington, D.C.:
April 6-10, 2013